Browse > Article
http://dx.doi.org/10.5653/cerm.2018.45.3.116

Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome  

Sak, Sibel (Department of Obstetrics and Gynaecology, Faculty of Medicine, Harran University)
Uyanikoglu, Hacer (Department of Obstetrics and Gynaecology, Faculty of Medicine, Harran University)
Incebiyik, Adnan (Department of Obstetrics and Gynaecology, Faculty of Medicine, Harran University)
Incebiyik, Hatice (Department of Endocrinology, Faculty of Medicine, Harran University)
Hilali, Nese Gul (Department of Obstetrics and Gynaecology, Faculty of Medicine, Harran University)
Sabuncu, Tevfik (Department of Endocrinology, Faculty of Medicine, Harran University)
Sak, Erdal (Department of Obstetrics and Gynaecology, Faculty of Medicine, Harran University)
Publication Information
Clinical and Experimental Reproductive Medicine / v.45, no.3, 2018 , pp. 116-121 More about this Journal
Abstract
Objective: The aim of this study was to compare serum fetuin-A levels and oxidative stress markers, as indicators of insulin resistance, in women with polycystic ovary syndrome (PCOS) and in healthy controls. Methods: This prospective case-control study included 46 patients with PCOS and 48 age- and body mass index-matched control women. Levels of serum hormones, fetuin-A, and oxidative stress markers were measured in blood samples taken during the early follicular period from each participant. Results: Follicle-stimulating hormone (FSH), luteinising hormone (LH), total testosterone levels, and the LH/FSH ratio were found to be significantly higher in women with PCOS than in controls. Serum total antioxidant status, total oxidant status, and oxidative stress index parameters all indicated significantly higher levels of oxidative stress in PCOS patients than in controls. Serum fetuin-A levels, which were analyzed as an indicator of insulin resistance, were higher in the PCOS group than in the control group ($210.26{\pm}65.06{\mu}g/mL$ and $182.68{\pm}51.20{\mu}g/mL$, respectively; p= 0.024). Conclusion: The data obtained from the present study suggest that higher levels of both serum fetuin-A and oxidative stress markers might be related with PCOS.
Keywords
Fetuin-A; Oxidative stress; Polycystic ovary syndrome;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 2013;14:95-109.   DOI
2 Uyanikoglu H, Sabuncu T, Dursun H, Sezen H, Aksoy N. Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study. Biomarkers 2017;22:643-7.
3 Isik H, Aynioglu O, Timur H, Sahbaz A, Harma M, Can M, et al. Is xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors? J Reprod Immunol 2016;116:98-103.   DOI
4 Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev 2016;2016:8589318.
5 Incebiyik A, Camuzcuoglu H, Vural M, Hilali NG, Camuzcuoglu A, Seker A, et al. Assessment of apoptotic activity dysregulation and oxidative stress in the development of epithelial ovarian cancer: a case-controlled descriptive analysis. Gynecol Obstet Invest 2016;81:71-7.   DOI
6 Incebiyik A, Vural M, Camuzcuoglu H, Taskin A, Camuzcuoglu A, Hilali NG, et al. Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole? Wien Klin Wochenschr 2016;128(Suppl 8):566-71.
7 Hizli S, Abaci A, Ozdemir O, Akelma Z, Akin O. Relation of fetuin A levels with cardiac, subcutaneous lipid accumulation and insulin resistance parameters in Turkish obese children. J Pediatr Endocrinol Metab 2016;29:669-73.
8 Kozakowski J, Jeske W, Zgliczynski W. Fetuin-A levels in lean and obese women with polycystic ovary syndrome. Endokrynol Pol 2014;65:371-6.   DOI
9 Gulhan I, Bozkaya G, Oztekin D, Uyar I, Kebapcilar AG, Pamuk B. Serum fetuin-A levels in women with polycystic ovary syndrome. Arch Gynecol Obstet 2012;286:1473-6.   DOI
10 Enli Y, Fenkci SM, Fenkci V, Oztekin O. Serum fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. Gynecol Endocrinol 2013;29:1036-9.   DOI
11 Tokmak A, Kokanali D, Timur H, Kuntay Kokanali M, Yilmaz N. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome. Gynecol Endocrinol 2016;32:926-30.   DOI
12 Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf) 2011;75:450-5.   DOI
13 Yin L, Cai WJ, Chang XY, Li J, Su XH, Zhu LY, et al. Association between fetuin-A levels with insulin resistance and carotid intimamedia thickness in patients with new-onset type 2 diabetes mellitus. Biomed Rep 2014;2:839-42.   DOI
14 Williams T, Mortada R, Porter S. Diagnosis and treatment of polycystic ovary syndrome. Am Fam Physician 2016;94:106-13.
15 Graff SK, Mario FM, Ziegelmann P, Spritzer PM. Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis. Int J Clin Pract 2016;70:450-61.   DOI
16 Layegh P, Mousavi Z, Farrokh Tehrani D, Parizadeh SM, Khajedaluee M. Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: comparison between obese and non-obese PCOS patients. Int J Reprod Biomed (Yazd) 2016;14:263-70.   DOI
17 Nasrat H, Patra SK, Goswami B, Jain A, Raghunandan C. Study of association of leptin and insulin resistance markers in patients of PCOS. Indian J Clin Biochem 2016;31:104-7.   DOI
18 Voelkl J, Pakladok T, Lin Y, Viereck R, Lebedeva A, Kukuk D, et al. Up-regulation of hepatic alpha-2-HS-glycoprotein transcription by testosterone via androgen receptor activation. Cell Physiol Biochem 2014;33:1911-20.   DOI
19 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
20 Barber TM, Dimitriadis GK, Andreou A, Franks S. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond) 2016;16:262-6.   DOI
21 Robinson KN, Teran-Garcia M. From infancy to aging: biological and behavioral modifiers of fetuin-A. Biochimie 2016;124:141-9.   DOI
22 Abali R, Celik C, Tasdemir N, Guzel S, Alpsoy S, Yuksel A, et al. The serum protein ${\alpha}2$-Heremans-Schmid glycoprotein/fetuin-A concentration and carotid intima-media thickness in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013;169:45-9.   DOI
23 Kucukaydin Z, Duran C, Basaran M, Camlica F, Erdem SS, Basaran A, et al. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome. J Endocrinol Invest 2016;39:1139-48.   DOI
24 Demir B, Cengiz H, Ungan I, Gedikbasi A, Karakoc G, Demir E, et al. The relationship between epicardial adipose tissue thickness and oxidative stress parameters in patients with isolated polycystic ovary syndrome. Gynecol Endocrinol 2015;31:531-5.
25 Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91.   DOI
26 Papalou O, Victor VM, Diamanti-Kandarakis E. Oxidative stress in polycystic ovary syndrome. Curr Pharm Des 2016;22:2709-22.   DOI